Does increasing life expectancy affect competing mortality after radical prostatectomy?

Urologic Oncology: Seminars and Original Investigations

Volumn 32, Issue 4, 2014, Pages 413-418

  Froehner, Michael ^a   Koch, Rainer ^a   Wirth, Manfred P ^a   Adam, Meike ^b   Schlomm, Thorsten ^b   Huland, Hartwig ^b   Graefen, Markus ^b  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Active surveillance; Competing mortality; Life expectancy; Prostate cancer; Radical prostatectomy; Survival

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGE DISTRIBUTION; ARTICLE; CANCER MORTALITY; CANCER STAGING; DEATH; FOLLOW UP; GLEASON SCORE; HUMAN; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; AGED; CANCER GRADING; GERMANY; MIDDLE AGED; MORTALITY; PROGNOSIS; PROSTATIC NEOPLASMS; RISK ASSESSMENT; SURVIVAL RATE;

AGED; FOLLOW-UP STUDIES; GERMANY; HUMANS; LIFE EXPECTANCY; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; PROGNOSIS; PROSTATECTOMY; PROSTATIC NEOPLASMS; RISK ASSESSMENT; SURVIVAL RATE;

EID: 84899488761     PISSN: 10781439     EISSN: 18732496     Source Type: Journal    
DOI: 10.1016/j.urolonc.2013.10.006     Document Type: Article

References (16)

1. Christensen K., Doblhammer G., Rau R., Vaupel J.W. Ageing populations: the challenges ahead. Lancet 2009, 374:1196-1208.
2. Read W.L., Tierney R.M., Page N.C., Costas I., Govindan R., Spitznagel E.L., et al. Differential prognostic impact of comorbidity. J Clin Oncol 2004, 22:3099-3103.
3. Cooperberg M.R., Broering J.M., Carroll P.R. Time trends and local variation in primary treatment of localized prostate cancer. J Clin Oncol 2010, 28:1117-1123.
4. Deutsche Gesellschaft für Urologie e. V. Interdisziplinäre Leitlinie der Qualität S3 zur Früherkennung, Diagnose und Therapie der verschiedenen Stadien des Prostatakarzinoms. Version 2.0-1. Aktualisierung, 2011. [Interdisciplinary guideline of S3 quality for early detection, diagnosis and treatment of the different stages of prostate cancer. Version 2.0-1st update 2011]. [accessed 21.09.13] [in German]. http://www.urologenportal.de/fileadmin/MDB/PDF/S3_LL_PCAS3_PCa_Aktualisierung_2011_110912f.pdf.
5. Heidenreich A, Bastian PJ, Bellmunt J, Bolla M, Joniau S, Mason MD,et al. EAU guidelines on prostate cancer. Update 2013. [accessed 21.09.13]. http://www.uroweb.org/gls/pdf/08%20Prostate%20Cancer_LR%20March%2013th%202012.pdf.
6. Statistisches Bundesamt. Periodensterbetafeln für Deutschland 1871/1881 bis 2008/2010 [Period death tables for Germany 1871/1881 bis 2008/2010], Wiesbaden, 2012. [accessed 21.09.2013] [Website in German]. https://www.destatis.de/DE/Publikationen/Thematisch/Bevoelkerung/Bevoelkerungsbewegung/PeriodensterbetafelnPDF_5126202.pdf?__blob=publicationFile.
7. Vogt T.C. How many years of life did the fall of the Berlin wall add? A projection of East German life expectancy. Gerontology 2013, 59:276-282.
8. Pintilie M. Competing Risks: A Practical Perspective 2006, 195-207. John Wiley & Sons, Chichester, England.
9. Doblhammer G., Kreft D., Dethloff A. Gewonnene Lebensjahre. Langfristige Trends der Sterblichkeit nach Todesursachen in Deutschland und im internationalen Vergleich. [Life years gained. Long-term trends in mortality by causes of death in Germany and in an international perspective.]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2012, 55:448-458. [in German].
10. Sierra F., Hadley E., Suzman R., Hodes R. Prospects for life span extension. Annu Rev Med 2009, 60:457-469.
11. Borre M., Erichsen R., Lund L., Larsen E.H., Nørgaard M., Jacobsen J.B. Survival of prostate cancer patients in central and northern Denmark, 1998-2009. Clin Epidemiol 2011, 3(Suppl. 1):41-46.
12. Klotz L., Zhang L., Lam A., Nam R., Mamedov A., Loblaw A. Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer. J Clin Oncol 2010, 28:126-131.
13. Wilt T.J., Brawer M.K., Jones K.M., Barry M.J., Aronson W.J., Fox S., et al. Prostate Cancer Intervention versus Observation Trial (PIVOT) Study Group. Radical prostatectomy versus observation for localized prostate cancer. N Engl J Med 2012, 367:203-213.
14. Selvadurai E.D., Singhera M., Thomas K., Mohammed K., Woode-Amissah R., Horwich A., et al. Medium-term outcomes of active surveillance for localised prostate cancer. Eur Urol 2013, [Epub ahead of print].
15. Shikanov S., Desai V., Razmaria A., Zagaja G.P., Shalhav A.L. Robotic radical prostatectomy for elderly patients: probability of achieving continence and potency 1 year after surgery. J Urol 2010, 183:1803-1807.
16. Froehner M., Garbrecht B., Hakenberg O.W., Koch R., Litz R.J., Oehlschlaeger S., et al. Changing comorbidity classification patterns at radical prostatectomy during a 10-year period. Urol Oncol 2007, 25:26-31.